Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has rapidly become a significant concern for women with textured breast implants in the last twenty years since it was first reported. 1 Cordeiro P.G. Ghione P. Ni A. Hu Q. Ganesan N. Galasso N. et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg. 2020; 73: 841-846 Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar The incidence appears to depend on texturization but a recent prospective cohort study reports the overall risk of BIA-ALCL is 1/355 women or 0.311 cases per 1000 person-years. 1 Cordeiro P.G. Ghione P. Ni A. Hu Q. Ganesan N. Galasso N. et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg. 2020; 73: 841-846 Abstract Full Text Full Text PDF PubMed Scopus (72) Google Scholar The highest overall risk reportes is associated with the use of macro-textured implants. 2 Collett D.J. Rakhorst H. Lennox P. Magnusson M. Cooter R. Deva A.K. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants. Plast Reconstr Surg. 2019; 143: 30S-40S Crossref PubMed Scopus (122) Google Scholar This risk was felt to be significant enough that the US Food and Drug Administration (FDS) recalled Allergan Natrelle BIOCELL-textured breast implants in July 2019. 3 Administration UFaD . The FDA requests Allergan voluntarily recall Natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients. In: Administration UFaD, editor. FDA safety communication. US2019. Google Scholar This has triggered a shift away from the accepted paradigm of textured anatomical implants back to the traditional smooth round implant.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Plastic, Reconstructive & Aesthetic Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
